ONI snaps up $75m Series B

ONI, a biotechnology company, has secured $75 million in Series B financing.

Iris Dorbian

20 January 2022

ONI, a biotechnology company, has secured $75 million in Series B financing. ARCH Venture Partners and Casdin Capital led the round.

Register now

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Not for publication, email or dissemination